Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation

被引:101
作者
Hlushchuk, Ruslan [2 ]
Riesterer, Oliver [3 ]
Baum, Oliver
Wood, Jeanette [4 ]
Gruber, Guenther [5 ]
Pruschy, Martin [3 ]
Djonov, Valentin [1 ,2 ]
机构
[1] Univ Fribourg, Inst Anat, CH-1700 Fribourg, Switzerland
[2] Univ Bern, Inst Anat, Bern, Switzerland
[3] Univ Zurich Hosp, Dept Radiat Oncol, CH-8091 Zurich, Switzerland
[4] Novatris Oncol AG, Basel, Switzerland
[5] Univ Hosp Bern, Dept Radiat Oncol, CH-3010 Bern, Switzerland
基金
瑞士国家科学基金会;
关键词
D O I
10.2353/ajpath.2008.071131
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Inhibitors of angiogenesis and radiation induce compensatory changes in the tumor vasculature both during and after treatment cessation. To assess the responses to irradiation and vascular endothelial growth factor-receptor tyrosine kinase inhibition (by the vascular endothelial growth factor tyrosine kinase inhibitor PYK787/ZK222854), mammary carcinoma allografts were investigated by vascular casting; electron, light, and confocal microscopy; and immunoblotting. Irradiation and anti-angiogenic therapy had similar effects on the tumor vasculature. Both treatments reduced tumor vascularization, particularly in the tumor medulla. After cessation of therapy, the tumor vasculature expanded predominantly by intussusception with a plexus composed of enlarged sinusoidal-like vessels containing multiple transluminal tissue pillars. Tumor revascularization originated from preserved alpha-smooth muscle actin-positive vessels in the tumor cortex. Quantification revealed that recovery was characterized by an angiogenic switch from sprouting to intussusception. Up-regulated alpha-smooth muscle actin-expression during recovery reflected the recruitment of alpha-smooth muscle actin-positive cells for intussusception as part of the angio-adaptive mechanism. Tumor recovery was associated with a dramatic decrease (by 30% to 40%) in the intratumoral microvascular density, probably as a result of intussusceptive pruning and, surprisingly, with only a minimal reduction of the total microvascular (exchange) area. Therefore, the vascular supply to the tumor was not severely compromised, as demonstrated by hypoxia-inducible factor-1 alpha expression. Both irradiation and anti-angiogenic therapy cause a switch from sprouting to intussusceptive angiogenesis, representing an escape mechanism and accounting for the development of resistance, as well as rapid recovery, after cessation of therapy.
引用
收藏
页码:1173 / 1185
页数:13
相关论文
共 49 条
[1]   Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165
[2]   Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors [J].
Bergers, G ;
Song, S ;
Meyer-Morse, N ;
Bergsland, E ;
Hanahan, D .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (09) :1287-1295
[3]   Immunohistochemical detection of cell growth fraction in formalin-fixed and paraffin-embedded murine tissue [J].
Birner, P ;
Ritzi, M ;
Musahl, C ;
Knippers, P ;
Gerdes, J ;
Voigtländer, T ;
Budka, H ;
Hainfellner, JA .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (06) :1991-1996
[4]   Intussusceptive angiogenesis: Its emergence, its characteristics, and its significance [J].
Burri, PH ;
Hlushchuk, R ;
Djonov, V .
DEVELOPMENTAL DYNAMICS, 2004, 231 (03) :474-488
[5]   Vascular remodeling by intussusceptive angiogenesis [J].
Djonov, V ;
Baum, O ;
Burri, PH .
CELL AND TISSUE RESEARCH, 2003, 314 (01) :107-117
[6]   Intussusceptive angiogenesis - Its role in embryonic vascular network formation [J].
Djonov, V ;
Schmid, M ;
Tschanz, SA ;
Burri, PH .
CIRCULATION RESEARCH, 2000, 86 (03) :286-292
[7]   Optimality in the developing vascular system: Branching remodeling by means of intussusception as an efficient adaptation mechanism [J].
Djonov, VG ;
Kurz, H ;
Burri, PH .
DEVELOPMENTAL DYNAMICS, 2002, 224 (04) :391-402
[8]  
Drevs J, 2002, CANCER RES, V62, P4015
[9]   Antiangiogenesis and drug delivery to tumors: Bench to bedside and back [J].
Duda, DG .
CANCER RESEARCH, 2006, 66 (08) :3967-3970
[10]   Antiangiogenic therapy: More promise and, yet again, more questions [J].
Ellis, LM .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (21) :3897-3899